The document discusses the Indian pharmaceutical sector facing regulatory hurdles in international markets like the US due to a shortage of drug inspectors. It notes there are around 1,500 inspectors for over 10,000 factories producing pharmaceutical products in India. The sector is facing challenges in markets like the US and EU. It provides technical analysis on Cipla, recommending selling within the range of 623-627, targeting 610. It also recommends buying BHEL within 167-169, targeting 173. It includes updates on US stocks, Asian stocks, and expected opening of Indian shares.

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Indian pharmaceutical sector is facing regulatory hurdles in the international markets, including the US, due to shortage of skilled
druginspectors,saysastudy.Therearearound1,500inspectorsformorethan10,000factoriesengagedinpharmaceuticalproducts
inthecountry,thestudy by Assochamandresearch firm RNCOSsaid.The Indianpharmaceuticalsector,whichmade rapidstrides in
theglobalmarkets,isnowfacedwithseveralregulatoryhurdles,especiallyintheUSandtheEU,itsaid.
Technical Outlook : Overall looking at Pharma sector, Cipla is the counter which is looking at this level. On daily chart, stock has
foramed Big Bearish candlestick with above average volume which showing accentuated selling pressure during the trading hours,
and can expect the same move in coming trading session. Moreover, recently stock faced strong resistance of its 200 DMA which is
placedat 648 level, which indicatesthat short tomediumtrend is down. A momentum indicator RSI readingis below 40 marks with
negative crossover, which point out for negative breath in the stock. So for trading perspective, one could Sell in the range of 623-
627fortheTargetof610swiththeSLof634.
CIPLA
BHEL
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
10th Dec 2015
Buy in the range of 167-169 for the Target of 173 with the SL of 165
Sell in the range of 623-627 for the Target of 610 with the SL of 634
Heavy Industry Minister AnantGeete clarifiedtothemediathat therewere noplansofdivestmentofthegovernment's stake inthe
BHEL. According to reports, Heavy Industry Minister Anant Geete has categorically denied that a propsoal of further stake sale in
BharatHeavyElectricals(Bhel)isbeingconsideredbythegovernmentatpresent.
Technical Outlook :InHourly chart,stock has givenpositivebreakout of its upper bandof fallingwedge pattern withabove average
volume, which shows that upside movement can be seen in coming trading session. A momentum indicator RSI has recently come
out from its oversold zone, with positive crossover, which point out for positive breath in the stock. So for trading perspective, one
couldBuyintherangeof167-169fortheTargetof173withtheSLof165
US stocks closed lower on Wednesday in a choppy session as oil resumed its decline, fuelling investor worries about
global economic growth and causing the S&P 500 index to track the move in the commodity. Asian stocks slipped on
Thursday as weak oil prices continued to feed global growth worries, while the euro held solid gains after a
policymaker poured cold water on market expectations of more easing by the European Central Bank. MSCI's
broadest index of Asia-Pacific shares outside Japan lost 0.2 percent.
Indian shares may open marginally in the green Thursday, after a six-day losing streak saw the benchmark off shave
4.3 percent, and even as other global equities are trading soft. At the time of writing, the SGX Nifty was trading 0.11
percent, or 8.5 points, higher to 7,655. There were a couple of Cabinet decisions yesterday, which may bring in focus
certain sectors: such as the move to approve the Real Estate Bill, mandating use jute in packaging for certain products
and certain steps the Cabinet took to promote the shipbuilding industry.

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
Colgate Palmolive (India) Limited; Interim Dividend Rs 3/- Per Share (Purpose Revised)
Prime Focus Limited; Annual General Meetng
J.Kumar Infraprojects Limited; Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs
5/- Per Share
Result Calendar:
10th Dec 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 09/12/2015 531731 AARYAGLOBL VISHAMBHAR LAL S 250000 2.62
2 9/12/2015 531731 AARYAGLOBL THINK BULL PRIVATE LIMITED S 200000 2.62
3 9/12/2015 531731 AARYAGLOBL THINK BULL PRIVATE LIMITED B 200000 2.62
4 9/12/2015 534731 BITL BHAVNABEN VIRENDRAKUMAR PATEL S 130582 22.63
5 9/12/2015 534731 BITL BHAVNABEN VIRENDRAKUMAR PATEL B 130582 22.61
6 9/12/2015 526957 UVBOARDS BHARAT SECURITIES PVT LTD B 130225 16.41
7 9/12/2015 526957 UVBOARDS BHARAT SECURITIES PVT LTD S 121205 16.34
8 9/12/2015 532972 SANKHYAIN BP FINTRADE PRIVATE LIMITED S 107676 37.49
9 9/12/2015 532972 SANKHYAIN BP FINTRADE PRIVATE LIMITED B 102431 37.19
10 9/12/2015 531867 UNITINT RAHUL RAI S 85326 6.60
IBREALEST

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
10th Dec 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website